SMALL CELL LUNG CANCER EXTENSIVE STAGE
Clinical trials for SMALL CELL LUNG CANCER EXTENSIVE STAGE explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL LUNG CANCER EXTENSIVE STAGE trials appear
Sign up with your email to follow new studies for SMALL CELL LUNG CANCER EXTENSIVE STAGE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to outperform standard care in aggressive lung cancer
Disease control Not yet recruitingThis Phase 3 trial will test whether a new drug called BL-M14D1 combined with atezolizumab works better than the current standard treatment for people with extensive-stage small cell lung cancer who have not had prior therapy. About 550 adults will be randomly assigned to receive…
Matched conditions: SMALL CELL LUNG CANCER EXTENSIVE STAGE
Phase: PHASE3 • Sponsor: SystImmune Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New drug combo aims to keep lung cancer in check after initial treatment
Disease control Not yet recruitingThis early-phase study tests whether adding an experimental drug (DSP-0390) to the immunotherapy atezolizumab can safely help prevent extensive stage small cell lung cancer from growing back after initial chemotherapy and immunotherapy. About 20 adults whose cancer did not worsen…
Matched conditions: SMALL CELL LUNG CANCER EXTENSIVE STAGE
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC